SharkNinja Recalls 1.8 Million Multi-Function Pressure Cookers
On May 1, 2025, SharkNinja Foodi OP Series Multi-Function Pressure Cookers were recalled due to the risk of burn injuries. The danger is that the lid of the pressure cooker could be opened by consumers while food was cooking, which could result in the hot material inside escaping and burning the consumer who’d opened the pot or bystanders. Around 1,846,400 pressure cooker units in the United States have been recalled. All of the Ninja Foodi OP300 Series Multi-Function Pressure Cookers are involved. If you were burned as a result of using a Ninja Foodi OP300 Series Multi-Function Pressure Cookers, you should consult the seasoned Chicago-based lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved.
Consult Moll Law Group About Your Claim
The SharkNinja lids may pop open while the pressure cooker is in use. When hot food escapes from the inside, the result may be severe or even catastrophic burn injuries. About 106 people have reported they were injured by using the SharkNinja and over 50 of these people reported that they suffered second or third degree burns to their face or body. More than 20 lawsuits have been filed against SharkNinja.
Affected SharkNinja pressure cookers were sold at Walmart, Costco, Sam’s Club, Amazon and Target stores around the country. Online retailers of the product are at www.Ninjakitchen.com, www.walmart.com, www.costco.com, www.samsclub.com, www.amazon.com and www.target.com from January 2019 through March 2025. The product sells for about $200.
Illinois Injury and Mass Tort Lawyer Blog


Two Alzheimer’s drugs Leqembi and Kisunla were approved by the FDA to treat mild dementia or a pre-Alzheimer’s condition called mild cognitive impairment. Data had suggested that Leqembi could slow cognitive decline in Alzheimer’s patients by five months over a period of 18 months for patients who had only mild symptoms. Two thousand volunteers had agreed to test Leqembi in clinical studies. However, it turns out these drugs may also increase the risk for brain bleeds and swelling in patients with certain genetic profiles—and patients may not have been given
On February 20, 2025, Super 73
Recently, the Food and Drug Administration issued a
The Triumph TF250-X Off-Road Motorcycle, which is imported by Triumph Motorcycles America, has been
Recently, after a three-week trial, jurors in a state court
Recently, ICU Medical, Inc.
4, the Chicago-based company Riverside Natural Foods
A multistate outbreak of listeria monocytogenes has impacted frozen supplement shakes made by Prairie Farms. As of February 21, 2025, 38 people have been infected by the outbreak across 21 states. On February 22, 2025, Lyons Magnus LLC
Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to manage type 2 diabetes and obesity and have the potential to help other medical problems like depression, addiction, and Alzheimer’s. Unfortunately, it also appears that one of the drugs’ potential side effects is a rare kind of vision loss, non-arteritic anterior ischemic optic neuropathy (